Dry Sarah M, Garrett Sarah B, Koenig Barbara A, Brown Arleen F, Burgess Michael M, Hult Jen R, Longstaff Holly, Wilcox Elizabeth S, Madrigal Contreras Sigrid Karina, Martinez Arturo, Boyd Elizabeth A, Dohan Daniel
Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, San Francisco, California, United States of America.
PLoS One. 2017 Feb 24;12(2):e0172582. doi: 10.1371/journal.pone.0172582. eCollection 2017.
United States-based biorepositories are on the cusp of substantial change in regulatory oversight at the same time that they are increasingly including samples and data from large populations, e.g. all patients in healthcare system. It is appropriate to engage stakeholders from these populations in new governance arrangements. We sought to describe community recommendations for biorepository governance and oversight using deliberative community engagement (DCE), a qualitative research method designed to elicit lay perspectives on complex technical issues. We asked for stakeholders to provide input on governance of large biorepositories at the University of California (UC), a public university. We defined state residents as stakeholders and recruited residents from two large metropolitan areas, Los Angeles (LA) and San Francisco (SF). In LA, we recruited English and Spanish speakers; in SF the DCE was conducted in English only. We recruited individuals who had completed the 2009 California Health Interview Survey and were willing to be re-contacted for future studies. Using stratified random sampling (by age, education, race/ethnicity), we contacted 162 potential deliberants of whom 53 agreed to participate and 51 completed the 4-day DCE in June (LA) and September-October (SF), 2013. Each DCE included discussion among deliberants facilitated by a trained staff and simultaneously-translated in LA. Deliberants also received a briefing book describing biorepository operations and regulation. During the final day of the DCE, deliberants voted on governance and oversight recommendations using an audience response system. This paper describes 23 recommendations (of 57 total) that address issues including: educating the public, sharing samples broadly, monitoring researcher behavior, using informative consent procedures, and involving community members in a transparent process of biobank governance. This project demonstrates the feasibility of obtaining meaningful input on biorepository governance from diverse lay stakeholders. Such input should be considered as research institutions respond to changes in biorepository regulation.
总部位于美国的生物样本库正处于监管监督发生重大变革的前夕,与此同时,它们越来越多地纳入来自大量人群(例如医疗系统中的所有患者)的样本和数据。让这些人群的利益相关者参与新的治理安排是合适的。我们试图通过参与式社区参与(DCE)来描述社区对生物样本库治理和监督的建议,DCE是一种定性研究方法,旨在引出公众对复杂技术问题的看法。我们邀请利益相关者就公立大学加利福尼亚大学(UC)大型生物样本库的治理提供意见。我们将该州居民定义为利益相关者,并从两个大城市地区洛杉矶(LA)和旧金山(SF)招募居民。在洛杉矶,我们招募了说英语和西班牙语的人;在旧金山,DCE仅用英语进行。我们招募了完成2009年加利福尼亚健康访谈调查且愿意在未来研究中被再次联系的个人。通过分层随机抽样(按年龄、教育程度、种族/族裔),我们联系了162名潜在参与者,其中53人同意参与,51人于2013年6月(洛杉矶)和9月至10月(旧金山)完成了为期4天的DCE。每次DCE都包括由训练有素的工作人员主持的参与者之间的讨论,并在洛杉矶进行同声传译。参与者还收到了一本描述生物样本库运作和监管的简报手册。在DCE的最后一天,参与者使用观众反应系统就治理和监督建议进行投票。本文描述了总共57条建议中的23条,这些建议涉及的问题包括:对公众进行教育、广泛共享样本、监测研究人员行为、采用信息充分的知情同意程序以及让社区成员参与生物样本库治理的透明过程。该项目证明了从不同的普通利益相关者那里获得有关生物样本库治理的有意义意见的可行性。在研究机构应对生物样本库监管变化时,应考虑此类意见。